Clinical Trial Update: GLP-1R Actions on Muscle and the Skeleton [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining GLP-1 receptor agonists' effects on muscle and the skeleton, enrolling participants with obesity-related musculoskeletal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Osteoporosis
• Sarcopenia
• Sarcopenic Obesity

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Musculoskeletal Abnormalities, Obesity | Phase 4 | Status: RECRUITING